1. Alexion says “no” to investor proactive sale demand — FDA approves first copycats of Novartis MS drug Gilenya — $178M stockpile of Merck ebola vaccine authorized — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Vivus Pharmaceuticals

Anonymous board for Vivus Pharmaceuticals


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    2
    Views:
    3,332
  2. Anonymous
    Replies:
    1
    Views:
    4,223
  3. Anonymous
    Replies:
    11
    Views:
    9,760
  4. Anonymous
    Replies:
    16
    Views:
    6,759
  5. Charley?
    Replies:
    288
    Views:
    63,444
  6. Anonymous
    Replies:
    13
    Views:
    5,478
  7. anonymous
    Replies:
    3
    Views:
    3,086
  8. Anonymous
    Replies:
    68
    Views:
    17,174
  9. Anonymous
    Replies:
    1
    Views:
    2,610
  10. Anonymous
    Replies:
    113
    Views:
    30,478
  11. Anonymous
    Replies:
    47
    Views:
    12,235
  12. Anonymous
    Replies:
    115
    Views:
    30,574
  13. Anonymous
    Replies:
    4
    Views:
    3,085
  14. Anonymous
    Replies:
    5
    Views:
    2,532
  15. Anonymous
    Replies:
    10
    Views:
    4,023
  16. Anonymous
    Replies:
    1
    Views:
    2,301
  17. Anonymous
    Replies:
    8
    Views:
    2,501
  18. Anonymous
    Replies:
    21
    Views:
    6,875
  19. Anonymous
    Replies:
    5
    Views:
    2,165
  20. Anonymous
    Replies:
    1
    Views:
    2,334

Thread Display Options

Loading...